The presence of L-type Ca2+ channels at the frog neuromuscular junction (nmj) was studied by monitoring changes in intracellular Ca*+ evoked in presynaptic terminals and perisynaptic Schwann cells (PSCs) and by studying the distribution of Ca'+ channels using a monoclonal antibody directed against the 012/s subunit of L channels. L-type Ca*+ channel agonist and antagonist had no effect on resting level of fluorescence and nerve-evoked Ca*+ responses in presynaptic terminals. However, depolarization of PSCs induced by KCI (25 mM) produced entry of Ca*+, which was prevented by L-type Ca*' channel blockers, (+)R Bay K 8644 or nimodipine.
Labeling of Ca'+ channels revealed an intracellular epitope with an irregular and spotty distribution along the endplate. Similar results were obtained with a fluorescent phenylalkylamine
a blocker of L-type Ca*' channels. Ca*' channel labeling remained in absence of nerve terminals but was absent after mechanical removal of nerve terminals and PSCs. Most Ca*+ channel spots were distributed in between bands of cholinergic receptors labeled with a-bungarotoxin-TRITC. Cross sections of motor endplates revealed that labeling of Ca2+ channels was found only at the level of the synaptic cleft and not all around the PSCs. We conclude that L-type Ca*+ channels are located in perisynaptic glial cells in an appropriate location to sense depolarization induced by neurotransmitters and thus may support possible roles of glial cells on synaptic function.
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Neurotransmitter release at chemical synapses is triggered by a transient entry of Cazf through Ca2+ channels (Augustine et al., 1987) . At frog and mouse neuromuscular junctions (nmj), Ca2+ channels involved in transmitter release are thought to be of the N and P types, respectively. At frog nmj, transmitter release and nerve-evoked Ca2+ entry in presynaptic terminals were blocked by the N-type Cazi channel blocker o-conotoxin GVIA (w-CgTx) (Kerr and Yoshikami, 1984; Robitaille et al., 1990 Robitaille et al., , 1993a , and Ca2+ channels were labeled with fluorescent o-CgTx (Robitaille et al., 1990 (Robitaille et al., , 1993a Cohen et al., 1991) . Similar results were obtained at the mouse nmj using P-type Ca2+ channel blockers such as the funnel web spider toxin or o-agatoxin-IVA-related peptides (LlinBs et al., 1992; Uchitel et al., 1992; Wray and Porter, 1993; Bowersox et al., 1995; Sugiura et al., 1995) . Despite these observations, there are still uncertainties regarding the possibility that other types of Ca'+ channels also are present at these nmj. Indeed, a number of reports indicated that synaptic transmission at these two synapses also was modulated by L-type Ca2+ channel agonist and antagonist (Publicover and Duncan, 1979; Atchison and O'Leary, 1987; Pancrazio et al., 1989; Ribera and Nastuk, 1989; Kawagoe et al., 1990) .
In the present study, we explored the possibility that L-type Ca2+ channels are present at the frog nmj and, in particular, that these channels are located in the perisynaptic Schwann cells (PSCs), glial cells at this synapse. Glial cells are appealing candidates because they are closely associated with synapses, possess L-type Cazf channels as well as a large variety of other ion channels (Barres et al., 1990; Ritchie, 1992) , are receptors for most neurotransmitters and, most importantly, react to neurotransmitters released during nerveevoked synaptic transmission (Dani et al., 1992; Chiu and Kriegler, 1994; Parpura et al., 1994) . At the frog nmj, PSCs send processes in between the nerve terminal and the muscle fiber at irregular intervals between the release sites ( Fig. 1) (Birks et al., 1960; Dreyer et al., 1973; Couteaux and PCcot-Dechavassine, 1974; Peper et al., 1974) . As with other glial cells, PSCs react to transmitter release during synaptic transmission and possess a variety of receptors (Jahromi et al., 1992 (Jahromi et al., , 1993 Reist and Smith, 1992; Georgiou et al., 1994; Robitaille, 1995) .
The presence of Ca2+ channels at PSCs of the frog nmj was revealed by the induction of depolarization-induced Ca2+ entry, which was not blocked by w-CgTx (Jahromi et al., 1992) but was modulated by an ATP receptor (P,, type) (Robitaille, 1995) . In the present study, two approaches were used to test for the presence of L-type Ca2+ channels at the frog nmj. First, we examined the ability of L-and N-type Ca2+ channel agonist and antagonist to affect Ca*+ entry in nerve terminals and PSCs. Second, L-type Ca2+ channel distribution was examined using a monoclonal antibody raised against L-type Ca2+ channels ( Vandaele et al., 1987 ). 
MATERIALS AND METHODS
Experiments were performed on nmj of cutaneous pectoris muscles of Runa pipiens frogs. Frog Ringer's solution contained (in mM): 120 NaCI, 2 KCl, 1 NaHCO,, 1.8 CaCl,, and 5 HEPES/NaOH, pH 7.2. Calcium imaging of PSCs. Nerve-muscle preparations were removed from the frogs and pinned down in a recording chamber coated with Sylgard. The membrane permeant form of the Ca2+ indicator fluo 3 (fluo 3-AM, Molecular Probes, Eugene, OR) was used for imaging Ca2+ changes in PSCs (Kao et al., 1989; Jahromi et al., 1992; Georgiou et al., 1994; Robitaille, 1995) . Preparations were incubated with a solution containing 10 pM fluo 3-AM with a final concentration of 1% dimethyl sulfoxide and 0.02% pluronic acid for 120-150 min at 21-23°C. Partial chelation of heavy metal ions was achieved with tetrakis (2-pyridylmethyl) ethylcncdiamine (20 pM; Molecular Probes) (Arslan et al., 1985; Jahromi et al., 1992) .
Changes in fluorescence intensity were detected with an intensified CCD camera system (Sonv camera XC-77 and a Hamamatsu intensifier. C-2487, Hamamatsu ?ity: Japan), and images were digitized by a corn: puter using the Image1 software (Universal Imaging, West Chester, PA). Additional magnification was obtained with an optizoom (Nikon, Missisauga, Canada). The excitation wavelength was 485 + 20 nm, and the emitted light was detected through a low pass filter with cutoff at 515 nm. Neutral density filters of at least 50% were used to minimize damage to the preparations caused by an excess of light energy. Some experiments were performed using a BioRad 600 laser scanning confocal microscope equipped with an argon ion laser (Hertfordshire, UK). The 488 nm line of the laser was attenuated to l%, and the emitted fluorescent signals were detected through a low pass filter with cutoff wavelength at 515 nm. A 40x water immersion lens was used (Nikon, 0.55 NA or Olympus, 0.75 NA, Tokyo, Japan). Surface nmj were located using transmitied light microscopy, which allows a reliable identification of PSCs (Georgiou et _.. al., 1994) . The fluorescence intensity (F) was measured eve; the area of the PSCs cell body, and the relative changes in fluorescence intensity were expressed as Local application of KC1 (25 mM) on PSCs was performed using micropipettes (tip diameter, 2-3 pm). The same solution used to perfuse the preparation was used to prepare the KC1 solution. This ensured that the only difference between the locally applied solution and the perfusion solution was the presence of KCl. The tip of the pipette was positioned close to the PSCs soma under visual control at high magnification (40x objective), and KC1 was applied with a 100 msec pulse of positive pressure applied to the pipette (5-10 PSI) with a Picospritzer II (General Valve, Fairfield, NJ). In some experiments, external Ca'+ ions were omitted and replaced by 5 mM MgCl,. In these experiments, the preparations were incubated for 30 min before any imaging was performed.
Imaging of Ca" entry in nerve terminals. Nerve terminals were loaded with the Ca2+ indicator fluo 3-AM as indicated above, and muscle contractions were prevented by blocking cholinergic receptors with ol-bungarotoxin (10 p&ml). In some instances, PSCs did not accumulate the Ca2+ indicator. leavine the nerve terminals available for Ca*+ imaging without any contamin&on by Ca2+ responses that could occur in the PSCs. On these nmj, no Ca2+ response could be obtained in PSCs using local applications of agonists that normally induce Ca*+ responses in these cells (ATP, adenosine, and muscarine) (Jahromi et al., 1992 (Jahromi et al., , 1993 Georgiou et al., 1994; Robitaille, 1995) , and no fluorescence could be detected after incubation with the Ca*+ shown). This indicates that Ca*+ lonophore Br-A23187 (data not responses obtained in these conditions were originating entirely from the presynaptic nerve terminals. Changes in fluorescence were measured using the line scan mode of the confocal and expressed as a percentage change, as indicated above. The scanning line was positioned over a linear portion of the nerve terminal that was perfectly in focus. The line scan procedure allows one to measure changes of fluorescence at 2 msec intervals. Staining and immunocytochemistry. Cutaneous pectoris muscles were dissected from the frogs and pinned down in a Sylgard-coated chamber. Preparations were fixed for 10 min with 3% p-formaldehyde prepared in normal frog Ringer's solution and rinsed 3 times for 30 min with frog Ringer's solution. Muscles were subsequently incubated in 0.3% Triton X-100 (Sigma, St. Louis, MO) in frog Ringer's solution for 30 min and 15 min in a solution containing 0.01% Triton X-100 and 0.2% casein in frog Ringer's solution (solution A). Preparations then were incubated with mouse monoclonal anti-ol2/S subunit of L-type Ca*+ channels (antibody mAb3007; Vandaele et al., 1987) (dilution l/20 to l/100 in solution A) for 5 hr at room temperature followed by 10 hr at 4°C. After three rinses of 30 min each with solution A, muscles were incubated at room temperature with a biotinylated donkey anti-mouse antibody (dilution 1:200, Jackson) for 60 min followed by three rinses for 20 min with solution A. The preparations were incubated with fluorescein isothiocyanate-conjugated streptavidin (20 &ml; Molecular Probes) for 2 hr in the dark, at room temperature. No labeling was observed when the primary antibody was omitted. In some experiments, the periodate-lysine-p-formaldehyde (PLP) fixative was used (McLean and Nakane, 1974) . The fixative contained 0.01 M Na+ m-periodate, 75 mM lysine, and 2%p-formaldehyde in a final concentration of 0.037 M phosphate buffer, pH 7.4. Phosphate buffer (0.1 M), pH 7.4, was used throughout the procedures when PLP was used as a fixative. Similar results were obtained with both fixatives.
To locate endplate areas, preparations were incubated with tetramethyl-rhodamine isothiocyanate-conjugated peanut agglutinin lectin (TRITC-PNA, 15 pg/ml, Sigma) in the dark for 10 min. In some experiments, cholinergic receptors (AChR) were labeled with TRITC-conjugated ol-bungarotoxin (a-BuTx-TRITC, Molecular Probes) (20 pg/ml) for 30 min.
Preparations were mounted onto glass slides in a solution of Slowfade antifade reagent (Molecular Probes) to reduce photobleaching. In double-labeled preparations, we used the dual wavelength configuration of the BioRad 600 confocal microscope. This configuration uses a 514 nm excitation wavelength, one photomultiplier tube detecting the green emitted light selected by a band pass filter (514-550 nm), and the second photomultiplier tube detecting the red emitted light selected by a low pass filter (cutoff at 590 nm). Green and red images acquired simultaneously are either presented separately or as one image where the red and green images are superimposed to reveal the relative spatial distribution of the two labels. Observations were performed using a 40x oil immersion lens (Nikon, 1.3 N.A.) .
Labeling with fluorescent phenylalkylamine.
In some experiments, the location of L-type Ca '+ channels was revealed using boron dipyrromethane difluoride-conjugated phenylalkylamine [(-)DM-BODIPY-PAA, which fluoresces green; Molecular Probes] (Knaus et al., 1992) . Live muscles were incubated with 50-500 nM (-)DM-BODIPY-PAA (prepared in frog Ringer's solution) for 8 min at room temperature and then rinsed with frog Ringer's solution. The (-)DM-BODIPY-PAA solution was prepared a few minutes before its use. The labeling was observed with a 40X water immersion lens under the confocal microscope within the next 20 min after the incubation.
Enzymatic treatment of presynaptic nerve terminals and PSCs. In some experiments, presynaptic nerve terminals and PSCs were treated with collagenase to facilitate their removal from muscle fibers (Betz and Sakmann, 1971; Peper and MacMahan, 1972; Robitaille et al., 1990) . Muscles were dissected out from the frogs and pinned down in a Sylgardcoated chamber, and AChRs were blocked with unlabeled WBUTX (20 pg/ml) to prevent possible muscle contractions during the collagenase treatment and mechanical displacement. Preparations also were stained with TRITC-PNA. Muscles were treated with a solution of 1666 U/ml collagenase type IX (Sigma) for 60-70 min at room temperature. The reaction was stopped by an incubation with cold (4°C) 0 Ca2+/5 Mg*+ frog Ringer's solution for 5 min, and the preparations then were placed in normal Ringer's solution. Under precise visual control, cell bodies of PSCs were sucked in a micropipette with a large tip (7-10 pM) and gently pulled away from the endplate area until completely removed. This maneuver was considered successful if no sign of PSC cell bodies and nerve terminal remained at the endplate area when observed with transmitted light. In addition, peanut agglutinin (PNA) labeling was displaced with the nerve terminal and PSCs, because the proteoglycan labeled by the lectin is attached to the basal lamina (Ko, 1987) . Preparations then were incubated with (-)DM-BODIPY-PAA, as described above. Cross sections of nmj. Localization of Ca*+ channels around the nerve terminal and PSCs was examined using cross sections of nmj. Preparations were processed for L-type Ca2+ channel labeling and incubated with TRITC-PNA, as indicated above. Preparations then were frozen and mounted in OCT (Miles Laboratories, Naperville, IL). Cross sections (20 pM) were made with a cryotome and collected on microscope slides. The sections were observed with the confocal microscope using the dual wavelength combination, as indicated above.
Denervation of nmj. For denervation of cutaneous pectoris muscles, frogs were anesthetized with MS-222 (tricaine, 0.3 mg/gm frog body weight) dissolved in frog Ringer's solution and injected in one of the lymphatic bags (total volume injected, between 100 and 200 ~1). A small incision was made in the skin, and the motor nerve of one cutaneous pectoris muscle was cut off with minimum damage to the muscle blood supply. The contralateral muscle was used as a nondenervated control. The incision then was sewn in place using silk sutures. The frogs recovered in a wet environment for 6 or 7 d. The animals then were killed by double pithing, and cutaneous pectoris muscles were dissected out from the frogs. Both muscles, denervated and nondenervated, were processed in parallel. To ascertain that no nerve terminal remained after denervation, live preparations were incubated for 1 min with 4-Di-2-Asp (10 pM in normal frog Ringer's solution). This stain labels specifically live presynaptic nerve terminals (Magrassi et al., 1987) . Preparations also were stained with TRITC-PNA, as indicated above. Images were obtained with the dual wavelength configuration of the confocal microscope using a water immersion lens (40X Olympus). After these observations, muscles were fixed and processed for immunocytochemistry of L-type Ca'+ channels as indicated above. The same nmj then were found and imaged for the presence of Ca2+ channels.
RESULTS
The presence of L-type Ca2+ channels at the frog nmj first was studied by measuring changes of intracellular Ca2+ in presynaptic nerve terminals and PSCs.
L-type Ca*+ channel agonist and antagonist do not change Ca*+ entry in presynaptic nerve terminals The presence of L-type Cazf channels in presynaptic nerve terminals was studied by measuring the effects of agonist and antagonist on nerve-evoked entry of Ca'+. Figure 2A illustrates a nerve terminal loaded with the fluorescent Ca2+ indicator fluo 3. Ca2+ changes evoked by a brief train of stimuli (100 Hz, 250 msec) were measured on the nerve terminal branch at the top of the figure using the line scan mode of the confocal microscope. Figure 2B shows Ca2+ responses in normal external Ca*+ (control), in presence of the L-type Ca2+ channel blocker nimodipine (2.5 PM), and in presence of the N-type Ca2+ channel blocker w-CgTx (1 PM). Nimodipine had no effect on nerve terminal Ca2+ responses, whereas w-CgTx completely and irreversibly blocked nerve-evoked Ca2+ entry. Similarly, the agonist enantiomer of Bay K 8644, (-)S Bay K 8644 (van Amsterdam et al., 1989; Ravens and SchGpper, 1990) , had no effect on the entry of Ca2+ in the nerve terminal (Fig. 2C,D) and did not modify the resting level of fluorescence in the nerve terminal (data not shown). However, o-CgTx (1 PM) blocked all Ca2+ entry evoked by nerve stimulations. The lack of effect of L-type Ca2+ channel agonist and antagonist is probably not attributable to the inability of the drugs to bind to the channels in a nondepolarized condition, because no additional effects were observed when nerve terminals were tonically depolarized by increasing external Kf concentration (5 mM) (data not shown). Hence, the results suggest that L-type Ca2+ channels are not present in nerve terminals and are not involved in the transient entry of Ca2+ induced by an action potential.
Functional L-type Ca*+ channels at PSCs To test for the presence of functional L-type Ca2+channels, changes of intracellular level of Ca2+ were monitored after membrane depolarization induced by local applications of KCl. Figure  3A -C illustrates typical Ca2+ responses elicited by KC1 in the presence or absence of external Ca*+. Figure 3A shows the Ca2+ level in four PSCs at rest in 0 Ca2'/.5 Mg2+ before local application of KCl. In Figure 3B , KC1 (25 mM) was applied and the image taken. No Ca2+ responses were elicited by KC1 when external Ca2+ was absent. The size of Ca2+ responses was on average only 23 ? 12% (3 muscles, 16 cells). However, after return to normal concentration of external Cazf, local application of KC1 now induced Ca2+ responses in the same four cells (Fig. 3C) . KClevoked Ca2+ responses were on average 125 5 23% (3 muscles, 12 cells), which is statistically different from the value obtained in absence of Ca2+ (p < 0.05, Student's paired t test). This indicates that depolarization by KC1 induces entry of Ca2*, possibly through Ca2+ channels. It is unlikely that KCl-induced responses in PSCs were caused by the release of neurotransmitter substances induced by nerve terminal depolarization, because similar responses in PSCs were observed when Ca2+ entry in nerve terminal was blocked by w-CgTx (data not shown; see also Jahromi et al., 1992) If CaZt entry is dependent on Ca2+ channel opening, it should be prevented by the use of Ca2+ channel blockers. In the presence of Cd" (20 PM), a nonspecific blocker of Ca2+ channels (Ritchie, 1992) , Ca2+ responses evoked by local applications of KC1 (25 mM) were abolished (34 2 17%; 3 muscles, 19 cells; p < 0.05, Student's paired t test). This indicates that Ca2+ entry is mediated by opening of Ca2+ channels.
Specific L-type Ca2+ channel blockers were used to characterize further the type of channels present on the PSCs. Figure 3E shows the Ca2+ fluorescence in two PSCs at rest in the presence of nimodipine (2.5 PM) and Figure 3F shows the same cells after local application of KCl. In the presence of nimodipine (2-20 PM), Ca2+ responses evoked by local application of KC1 (25 mM Amsterdam et al., 1989; Ravens and Schopper, 1990) , (+)R Bay K 8644 (2 PM), was used (23 t 9%; 2 muscles, 11 cells) (see also Robitaille, 1995) . These results allow us to conclude that the entry of Ca '+ induced by membrane depolarization is mediated by the activation of L-type Ca2+ channels.
L-type Ca*+ channels are located at the endplate To locate Ca2+ channels, preparations were incubated with a monoclonal antibody, mAb3007, directed against the ~~216 subunit component in the L-type Ca2+ channel molecular complex ( Vandaele et al., 1987) . This antibody has been shown to bind to frog muscle membranes (Vandaele et al., 1987) . Endplates labeled with TRITC-PNA first were located with the fluorescent microscope and then examined in detail using the confocal microscope. A typical nmj is illustrated in Figure 4A . Labeling of the cu2/6 subunit of Ca2+ channels revealed the presence of several spots aligned at irregular intervals along the endplate, with a lower density at the PSCs soma (awow). Staining can be detected underneath the cell body area when nmj are observed on the side of muscle fibers (data not shown). Muscle fibers also were labeled at the level of the Z bands where L-type Ca2+ channels are present (Jorgensen et al., 1989; Flucher et al., 1990; Toutant et al., 1990) . However, this staining cannot be seen in Figure 44 because of the narrow depth of field caused by the confocal effect. No staining was observed on myelinating Schwann cells or on other cellular elements of the nerve-muscle preparation.
To rule out the possibility that the labeling pattern observed was attributable to trapping of the antibody in the synaptic cleft, the membrane permeabilization step was omitted (no Triton X-100 added) and the labeling procedure performed as described. Moreover, because the epitope recognized by antibody mAb3007 was intracellular (Vandaele and Rieger, 1994) , the lack of permeabilization should prevent the labeling if it was not caused by trapping of the antibodies in the synaptic cleft. Preparations were fixed with PLP fixative to reduce nonspecific labeling. No staining could be observed at the endplate area or in the muscle fiber (Fig. 4B) indicating that the access to the interior of the cell was necessary to label Ca2+ channels and rule out the possibility that the labeling at the endplate area could be caused by trapping of the antibody in the synaptic cleft.
Labeling of L-type Ca*+ channels by a phenylalkylamine Cazt channels are composed of several subunits (Hofmann, 1994) . The use of antibody mAb3007 reveals the location of the ~216 subunit of the Ca2+ channels, which could be present in other types of Ca2+ channels (Witcher et al., 1993) . Because the Cal subunit is unique to the L-type Ca2+ channel, we wondered whether labeling of the al subunit of the channels would reveal a pattern similar to the a2/6 subunit immunoreactivity. The al subunit of L-type Ca" channels was labeled with a fluorescent PAA, an L-type Ca2+ channel antagonist (Knaus et al., 1992 ). An endplate labeled with (-)DM-BODIPY-PAA is illustrated in Figure 4C . Similar to the antibody labeling, the staining observed with (-)DM-BODIPY-PAA was found at the nerve endplate and Z bands of the muscle fibers. Moreover, (-)DM-BODIPY-PAA labeling at the endplate revealed a spotty pattern similar to the Figure 4 . Labeling of L-type Ca*+ channels is located at the motor endplate. A, Labeling of a2/6 subunit with the antibody mAb3007 (L-WCC) revealed a spotty and irregular pattern. The a216 immunoreactivity was found only at the motor endplate as indicated by the presence of PNA staining (PWt). Note that almost no labeling was observed in the cell body area of the PSCs (avow). B, Labeling with the antibody mAb3007 in absence of membrane permeabilization with Triton X-100 (L-WCC). Note the absence of labeling at the endplate area revealed by the presence of the TRITC-PNA staining @WI). The antibody recognizes an intracellular epitope. C, Labeling of L-type Ca" channels with (-)DM-BODIPY-PAA (L-WCC) showed an irregular and spotty pattern comparable to the one observed with the antibody labeling. The (-)DM-BODIPY-PAA labeling also is restricted to the endplate area indicated by the presence of PNA staining. J. Neurosci., January 1, 1996, 76(1):148-158 153 one observed with antibody mAb3007. The labeling observed with (-)DM-BODIPY-PAA was abolished when the preparations were preincubated for 30 min with verapamil, an L-type Ca2+ channel antagonist (50 JLLM; Sigma), indicating that the labeling was caused by the binding to L-type Ca2+ channels.
Although the use of a confocal microscope allows one to examine a thin portion of the sample, the small size of the nerve terminal and the PSC processes precludes any conclusion on the exact location of L-type Ca2+ channels at the endplate area. Thus, the next series of experiments was aimed at determining on which cellular element of the nmj the Ca2+ channels are located.
L-type Ca*+ channel labeling remains in absence of nerve terminals If L-type Ca2+ channels are located in the presynaptic terminals, no labeling should be observed when the nerve terminals are absent. To test that possibility, cutaneous pectoris muscles were denervated for 6-7 d before labeling Ca2+ channels. This period is sufficient to induce the degeneration of a majority of nerve terminals (Birks et al., 1960; Cohen et al., 1991) . The vital dye 4-Di-2-ASP, which labels presynaptic terminals (Magrassi et al., 1987) was used to test for the presence of nerve terminals. Live preparations were incubated with 4-Di-2-ASP (10 FM), endplate areas were disclosed using TRITC-PNA, and images of 4-Di-2-ASP and PNA labeling were obtained simultaneously with the confocal microscope. After this observation, the preparations were fixed and Ca2+ channels labeled with antibody mAb3007. After fixation, 4-Di-2-ASP labeling disappears. An example of an endplate from an intact muscle (i.e., not denervated) is presented in Figure 54 . All nmj identified with the lectin (Fig. 5A , PNA) showed labeling of nerve terminals with 4-Di-2-ASP, and the same nmj could be found after the immunocytochemistry procedure, which revealed the presence of L-type Ca2+ channels (Fig. 5A, 
L-YDCC).
When the same procedure was performed on denervated muscles, no presynaptic nerve terminal staining was observed (Fig. 5B, 4Di-2-A,!?) at any of the nmj identified with the lectin (Fig. 5B , PNA), indicating that presynaptic terminals were absent. However, labeling of L-type Ca2+ channels (Fig. 5B , L-WCC) still was observed in all nmj identified. Although the presence of L-type Ca2+ channels in presynaptic nerve terminals cannot be completely ruled out, the persistence of L-type Cazt channel immunoreactivity after denervation suggests that these channels primarily are located in structures other than the presynaptic terminals of the frog nmj.
L-type Ca*+ channel labeling is displaced by removal of PSCS If L-type Ca2+ channels are not located at the presynaptic terminals, only two possibilities remain: in the plasma membrane of the muscle fiber or at the PSCs. To discriminate between these two possibilities, PSCs were removed mechanically from the endplate area after enzymatic digestion of the connective tissue. In this situation, if L-type Ca2+ channels are located in the PSCs, no labeling should be observed at the endplate area. On the other hand, the labeling should remain if the channels are located in the plasma membrane of the muscle fiber. Figure 64 shows an nmj labeled with TRITC-PNA after collagenase treatment. In Figure  6B , a PSC of the same nmj is being pulled away with a micropipette until it is completely removed from the endplate area (Fig.  6C) . The absence of lectin staining confirms that nerve terminal and PSCs were removed from this area. As shown in Figure 60 , no Cazt channels labeled with (-)DM-BODIPY-PAA were ob- January 1, 1996, 16(1):148-X8 served at the nmj area where PSCs and nerve terminal were removed, but were present on a branch of the same nmj that was not yechanically removed. In all cells tested, no labeling of Ca2+ chadnels could be observed after enzymatic treatment with collagenase and mechanical removal of the PSCs. Therefore, these results indicate that L-type Ca'+ channels are located in the PSCs and not in the plasma membrane of the muscle fiber. The lack of labeling is not attributable to the removal of Ca*+ channels by the enzymatic treatment alone, because Ca2+ channel staining still was observed at Z bands and at endplates where PSCs were not removed mechanically. It also is unlikely that Ca2+ channels were removed mechanically from the muscle fiber, because AChRs remained in place after such procedure, even though L-type Ca2+ channel labeling was removed (data not shown).
L-type Ca*+ channels are clustered between bands of AChRs The irregular pattern of distribution of L-type Ca2' channels is very reminiscent of the distribution of finger-like processes of the PSCs and, hence, suggests that these channels are located at the processes. If this hypothesis is correct, spots of L-type Ca2+ channel labeling should be located at irregular intervals between the bands of the AChRs. L-type Cazt channels labeled with antibody mAb3007 (L-VDCC) and AChRs labeled with TRITCconjugated ol-BuTx (a-BuTx) at the same endplate were observed simultaneously with the confocal microscope. The typical banding pattern at 1 pm intervals of AChRs was observed. If L-type Ca2+ channel and AChRs labeling patterns are identical, superimposition of the two images @ould produce a yellow image (green and red give yellow). Conver'sely, if the two patterns are different, the superimposed image should present mainly green and red pixels. As illustrated in Figure 7A (merged) and B, superimposition of the two images shows that the majority of L-type Ca2+ channel spots lie in between bands of AChRs. The overlap between L-type Cazt channel labeling and bands of labeled AChRs is consistent with the interposition of PSC fingers between nerve terminals and muscle fibers near active zones (Herrera et al., 1985) .
L-type Ca*+ channels are not clustered all around the PSCs The labeling pattern of L-type Ca*+ channels is consistent with the hypothesis that these channels are located in the finger-like processes of the PSCs, rather than distributed all around the circumference of PSCs. If this is the case, cross sections of nmj should reveal a discrete Ca2+ channel immunoreactivity in the synaptic cleft, and not an annulus of labeling around the PSCs. PNA was used as an indicator of the location of the synaptic cleft,
because it labels a proteoglycan associated with the basal lamina (Ko, 1987) . Ca 2+ channels were labeled with the monoclonal antibody mAb3007. Figure 8 shows a cross section of an endplate double-labeled for L-type Ca2+ channels (green) and PNA (red). The green and red images were acquired simultaneously and are superimposed to show the relative position of each label. L-type Ca2+ channel immunoreactivity was limited to the synaptic cleft, colocalized with the lectin labeling (green and red give yellow).
No labeling was observed elsewhere around the PSC. Thus, these results suggest that L-type Ca*+ channels are clustered at the finger-like processes of PSCs located near the transmitter release sites.
DISCUSSION
We showed in this study that L-type Ca2+ channels are not involved in nerve-evoked Ca2' entry in nerve terminals of the frog nmj but are present and not evenly distributed along the perisynaptic glial cells. The mismatch between the irregular labeling pattern of L-type Ca *+ channels and the regular distribution of postjunctional folds, combined with the use of various experimental protocols, indicated that L-type Ca2+ channels are likely to be clustered at the finger-like processes of PSCs.
L-type Ca*+ channels at PSCs of the frog nmj The lack of effects of L-type Ca2+ channel agonist and antagonist on nerve-evoked Ca*+ responses in presynaptic terminals, as well as the characteristics of the labeling pattern of the channels, suggests that L-type Ca*+ channels are not located in the nerve terminals. Moreover, the complete and irreversible blockade of transmitter release by o-CgTx (Robitaille et al., 1993a ) is a strong indication that there is only one type of Ca2+ channel regulating transmitter release, which is probably an N-type. Notwithstanding these observations, one cannot rule out completely that L-type Ca2+ channels are present in nerve terminals, because they could be present in low density not detected by the labeling assays and involved in other forms of modulation of transmitter release not related to action potentials. The blockade of depolarization-induced Ca2+ responses in PSCs by L-type Ca2+ channel antagonists and not by the N-type Ca2+ channel blocker o-CgTx (Jahromi et al., 1992) indicates that Ca2+ channels in PSCs are likely to be of the L-type. In addition, the persistence of the staining in absence of nerve terminals, combined with the mechanical displacement of the labeling, confirms that L-type Ca*+ channels are primarily in PSCs rather than in the nerve terminal or the membrane of the muscle fiber. This conclusion also is supported by the labeling observed with the L-type Ca2+ channel labeling remains in absence of presynaptic nerve terminals. A, False color images of a normal (innervated) frog nmj observed after staining of the nerve terminals with the vital dye 4-Di-2-ASP. The preparation also was stained with the lectin (PNA) to confirm the presence of the endplate area. The preparation was observed using the dual wavelength mode of the confocal. After the observations of 4-Di-2-ASP, the preparations were fixed and processed for immunocytochemistry to reveal the L-type Ca '+ channels. The same nm' was found and imaged for the location of CaZt channels (L-V'DCC). Note that the same nmj could be visualized for nerve terminal staining and L-type Ca A+ channels. B, Neuromuscular junction from a 6 d denervated preparation on which the same procedure as in A was applied. Note the presence of L-type Ca *+ channel labeling (L-WCC) even though there was no evidence for any nerve terminal staining with 4-Di-2-ASP. L-type Ca *+ channels are clustered between bands of AChRs. A, False color images showing L-type Ca*+ channels (L-VDCC, green) and bands of AChRs (W&T., red). The two images are superimposed (merged) to illustrate the relative distribution of L-type Ca*+ channels and AChRs. B, Enlargement of a portion of the nmj delimited by the box in A. Note that a majority of spots of L-Ca '+ channels are located between bands of AChRs. Some spots do overlap and appear yellow (green and red gives yellow). Figure 8 . Top right. Cz?' channels are clustered in the processes of PSCs in the synaptic cleft. False color image of a cross section of a frog nmj. Green and red images were acquired simultaneously and superimposed. Ca" channels Cpreen) were labeled with antibody mAb3007 and the basal lamina was labeled with TRlTC-PNA (red). The labeling of Ca*+ channels is confined in the synaptic cleft surrounded by the PNA staining and appears ye&w. Ltypc Ca*+ channels are restricted to the fine processes and not all around PSCs. The diagram illustrating the cross section is presented with the box of the area scanned by the confocal. January 1, 1996, 16(1) The box represents the area scanned by the confocal microscope. fluorescent PAA, a blocker of L-type Cazt channels. The presence of N-type Cazt channels at PSCs is unlikely because no labeling was observed on PSCs with w-CgTx (Robitaille et al., 1990; Cohen et al., 1991) . The presence of L-type Cazt channels in PSCs is consistent with what is found in other types of glial cells, because this is one of the most common types of Ca2+ channels found in these cells (MacVicar, 1984; Barres et al., 3990; Verkhratsky et al., 1990; MacVicar et al., 1991; Ritchie, 1992; Kirischuk et al., 1995) .
However, there is a possibility that the antibody mAb3007 also labels other types of Ca2+ channels, because the 012 subunit may be common to multiple types of channels, in particular, N-type Ca2+ channels (Witcher et al., 1993) and because these channels are likely to be present in presynaptic nerve terminals of frog nmj (Kerr and Yoshikami, 1984; Robitaille et al., 1990 Robitaille et al., , 1993a Cohen et al., 1991) . This possibility is unlikely for several reasons. For instance, labeling of N-type Ca2+ channels with o-CgTx shows a regular banding pattern of 1 pm, which matches the pattern of the cholinergic receptors labeled with fluorescent CX-BuTx, suggesting the presence of Ca2+ channels at release sites (Robitaille et al., 1990 (Robitaille et al., , 1993a Cohen et al., 1991) . However, in the present study, unlike the banding pattern of labeling with o-CgTx, the patterns observed with antibody mAb3007 or (-)DM-BODIPY-PAA were spotty, were not similar in pattern and shape to the cholinergic receptor staining and, finally, remained after disappearance of the presynaptic terminals. Finally, the presence of labeling at the Z bands of muscle fibers is a strong indication that the probes indeed did demonstrate the distribution of L-type Ca2+ channels (Jorgensen et al., 1989; Flucher et al., 1990; Toutant et al., 1990) . The lack of labeling by antibody mAb3007 of N-type Ca2+ channels in presynaptic nerve terminals may indicate that the LY~/S subunit is not part of the presynaptic Cazc channel complex or that the subunit is present but different from the PSCs Cazi channel subunit. Alternatively, the threedimensional organization of the presynaptic Ca2+ channel complex is such that the antibody does not reach the a/26 subunit. Hence, we conclude that L-type Ca2+ channels are present at PSCs of the frog nmj.
Subcellular distribution
of receptors and channels in glia Several examples of the subcellular distribution of receptors and ion channels in various glial cell types have been described (Rawlins and Villegas, 1978; Newman, 1986; Cull-Candy et al., 1989; Wilson and Chiu, 1990; Chiu, 1991; Derouiche and Frotscher, 1991; Sontheimer and Waxman, 1993; Miiller et al., 1994; Kirischuk et al., 1995) . The common feature of these observations is the nonuniform distribution of channels and receptors, with a clear tendency for their location away from the cell body. Derouiche and Frotscher (1991) showed that the enzyme glutamine synthetase, responsible for glutamate degradation, was found in glial cell processes near glutamatergic synapses in rat hippocampus. Thus, it appears that glial cells present a specialized distribution of functional elements that allow them to perform specific tasks associated with neuronal activity. The results of the present study provide a description of the location of functional molecules at a synapse in situ. The mismatch between the spotty and irregular pattern of L-type Ca2+ channel labeling and the regular banding pattern of AChR staining, combined with the observations that Cazt channels are clustered in a glial structure located in the synaptic cleft, strongly suggests that L-type Ca2+ channels are located in PSC processes in close anatomical contact with the synapse and clustered near transmitter release sites. This possibility is supported further by the observation that some spots of Ca*+ channel labeling overlapped with a portion of AChR bands. Indeed, this overlap is consistent with the observation that a certain percentage of PSC processes partially covers active zones at the frog nmj (Herrera et al., 1985) . Experiments using electron microscopy are in progress to confirm this possibility.
Functional significance of Ca2+ channel location near the release sites Several effects of glial Ca2+ channel activation have been shown, and diverse roles such as modulating phosphorylation and dephosphorylation activity have been proposed, triggering release of substances (Martin, 1992) controlling myelin formation during the development of oligodendrocytes (Kirischuk et al., 1995) or regulating glial cell activity during seizure (MacVicar et al., 1991) .
However, very little is known about glial Ca2+ channels around synapses. Smith (1992) modeled the effects of glial Cazt channel activation on the Ca2+ concentration in the synaptic cleft of a synapse in the central nervous system. The model indicates that such activation of glial Ca2+ channels would produce a local reduction of the cleft Ca2+ concentration and, because of the sensitivity of transmitter release to Ca2+, would result in a reduction in the amount of transmitter released. Such a mechanism may be present at the frog nmj because of the location of glial Ca2+ channels near transmitter release sites. In addition to their precise location, L-type Ca2+ channels at PSCs also are functional and modulated by a P,, receptor after release of endogenous ATP during synaptic activity (Robitaille, 1995) . However, because the size of the synaptic cleft at the nmj is much larger than at central synapses, this mechanism may not be as powerful here as it is suggested for a synapse of the central nervous system. Because Ca2+ is a ubiquitous second messenger controlling a large number of cellular functions, appealing alternatives, among others, would be that Ca2+ entry through L-type Ca2+ channels may regulate gene expression (Murphy et al., 1991) or trigger the release of substances susceptible to modulate transmitter release (Martin, 1992) .
It has been shown that L-type Ca*+ channel antagonists and agonists at mouse, lizard, and amphibian nmj modulated synaptic activity (Publicover and Duncan, 1979; Atchison and O'Leary, 1987; Lindgren and Moore, 1989; Ribera and Nastuk, 1989; Kawagoe et al., 1990) . In light of the present results, one may suggest that the modulation of transmitter release by the pharmacological agents acting on L-type Ca2+ channels is mediated indirectly by modulating the activity of perisynaptic glial cells, which in turn would modify the activity of the synapse.
Precise location of channels and receptors at PSCs: a glial "active zone"
Glial cells may modulate synaptic activity, owing to their close anatomical contact with synapses and their sensitivity to neurotransmitters. For that purpose, it is important for the glial cellular elements involved in such action to be located near transmitter release sites (Derouiche and Frotscher, 1991; Smith, 1992) . The discrete and precise location of Ca*+ channels at PSCs suggests the presence of an organized molecular machinery at perisynaptic glial cells such that other ion channels, receptors, and pumps also may be clustered at the processes, close to the sites of transmitter release. Hence, we propose a model in which functional molecules are located in the finger-like processes, highly organized elements strategically positioned to detect and perhaps modulate neurotransmitter release. January 1, 1996, 16(1) 
